Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Mesothelioma × Injections × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 13 Myelodysplastic Syndromes 8 Lung Neoplasms 4 Leukemia, Myelomonocytic, Chronic 4 Myeloproliferative Disorders 3 Head and Neck Neoplasms 3 Breast Neoplasms 3 Stomatitis 2 Sarcoma 2 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Multiple Myeloma 2 Mucositis 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Biphenotypic, Acute 2 Disease 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Prostate Cancer Metastatic 1 Primary Myelofibrosis 1 Neoplasms 1 Neoplasm Metastasis 1 Myelodysplastic-Myeloproliferative Diseases 1 Mouth Neoplasms 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1

Interventions

Pemetrexed 11 Cisplatin 10 pembrolizumab 7 Carboplatin 6 Ipilimumab 5 Nivolumab 4 durvalumab 3 LMB-100 3 Gemcitabine 3 tremelimumab 2 tazemetostat 2 anetumab ravtansine 2 Vinorelbine 2 Plicamycin 2 Dexamethasone 2 Cyclophosphamide 2 Bevacizumab 2 vandetanib 1 tocilizumab 1 ribociclib 1 rebastinib 1 pevonedistat 1 olaparib 1 niraparib 1 nintedanib 1 fludarabine phosphate 1 fludarabine 1 epacadostat 1 enzalutamide 1 defactinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡